Flecainide Acetate Tablet
Product Images NDC 57237-064

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Flecainide Acetate (NDC 57237-064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Rising® NDC 57237-063-01 is a tablet medication containing 50mg of Flecainide acetate USP. This drug is distributed by Rising Health, LLC and manufactured in India. Dosage information can be found in the package insert. The package is a bulk package and should be dispensed in a tight light-resistant container. The tablets should be stored at 20° to 25°C (68° to 77°F). This information was last revised in 12/2017.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (150 mg (100 Tablets Bottle))

Rising® is a medication that comes in tablet form containing 150mg of Flecainide Acetate USP. The tablets are packaged in bulk size of 100 tablets, and usual dosage should be followed as per package insert. Pharmacists are advised to dispense the medication in light-resistant containers and store it in controlled room temperature. The medication is distributed by Rising Health, LLC based in Saddle Brook, NJ, and it is manufactured in India.*

FDA Label Image

Chemical Structure (Flecainide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.